新型迭代去噪与图像增强技术在腹部T1加权平扫及增强梯度回波成像中的应用:图像质量与诊断信心的提升
这项回顾性单中心研究纳入50例腹部MRI患者,在采集参数不变的前提下,用同一原始数据经新型迭代去噪与增强算法重建出VIBEDE数据集,与标准VIBES对比。两位放射科医师采用1–4分Likert量表盲法评价,VIBEDE在器官与血管锐利度、噪声、整体图像质量、病灶可检出性及诊断信心上均优于VIBES(均P<0.0001或P≤0.001)。
要点
- VIBEDE在平扫与增强期的器官及血管锐利度中位评分均为4分(四分位距0),高于VIBES的3分(1)(均P<0.0001)。
- VIBEDE平扫噪声中位评分为4分(0),高于VIBES的3分(1);增强期VIBEDE为4分(0),高于VIBES的3分(0)(读者2为3分[1])(均P<0.0001)。
- 27例含肝脏病灶的研究中,VIBEDE病灶可检出性评分优于VIBES(读者1中位4分[0]对4分[1],P=0.001;读者2中位4分[0]对3分[1],P<0.001),诊断信心也更高(中位4分[0]对4分[0],P=0.001)。
关键影像表现/征象
- 平扫与增强期器官锐利度及血管锐利度在VIBEDE中位评分均为4分(四分位距0),VIBES为3分(1),两位读者评价均显著更优(均P<0.0001)。
- 平扫噪声VIBEDE中位4分(0)优于VIBES的3分(1);增强期VIBEDE中位4分(0)优于VIBES的3分(0)(读者2为3分[1])(均P<0.0001)。
- 整体图像质量VIBEDE中位4分(0)高于VIBES的3分(1)(P<0.0001)。
- 27例含肝脏病灶的研究中,两位读者之间及VIBES与VIBEDE之间病灶数目和定位无差异;病灶可检出性VIBEDE更优,读者1中位4分(0)对4分(1)(P=0.001),读者2中位4分(0)对3分(1)(P<0.001)。
- 诊断信心VIBEDE显著优于VIBES,两者中位均为4分(0)(P=0.001)。
诊断标准与关键数值
- 图像质量、噪声、锐利度、伪影、诊断信心及病灶可检出性均采用1–4分Likert量表,4分为最佳。
- 读者间一致性:平扫分析Cohen κ=0.76,增强分析Cohen κ=0.76。
临床应用与阅片要点
- 在采集参数不变的前提下,用同一原始数据进行迭代去噪与增强重建即可在不增加扫描时间的情况下改善图像锐利度和噪声评分。
- 该技术可能提升肝脏病灶的可检出性和诊断信心,但原文未报告敏感度、特异度或AUC等诊断效能指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to investigate the impact of a novel iterative denoising and image enhancement technique in T1-weighted precontrast and postcontrast volume-interpolated breath-hold examination (VIBE) of the abdomen on image quality, noise levels, and diagnostic confidence without change of acquisition parameters.
MATERIALS AND METHODS: Fifty patients were included in this retrospective, monocentric, institutional review board-approved study after clinically indicated magnetic resonance imaging of the abdomen including T1-weighted precontrast and postcontrast imaging. After acquisition of the standard VIBE (VIBES), images were processed with a novel reconstruction algorithm using the same raw data as for VIBES, resulting in a denoised and enhanced dataset (VIBEDE). Two different radiologists evaluated both datasets in a randomized order regarding sharpness of organs as well as vessels, noise levels, artifacts, overall image quality, and diagnostic confidence using a Likert scale ranging from 1 to 4 with 4 being the best. Furthermore, in the presence of focal liver lesions, the largest lesion was measured in the postcontrast dataset, and lesion detectability was analyzed using a Likert scale (1-4).
RESULTS: Precontrast and postcontrast sharpness of organs and sharpness of vessels were rated significantly superior by both readers in VIBEDE with a median of 4 (interquartile range, 0) compared with VIBES with a median of 3 (1) (all P's < 0.0001). Precontrast and postcontrast noise levels were also rated superior by both readers in VIBEDE with a median of 4 (0) compared with VIBES with a median of 3 (1) for precontrast and a median of 3 (0) (median of 3 [1] for reader 2) for postcontrast imaging (all P's < 0.0001).Overall image quality was also rated higher with a median of 4 (0) in VIBEDE versus 3 (1) in VIBES (P < 0.0001). Twenty-seven imaging studies contained liver lesions. There was no difference regarding the number and localization between the readers and between VIBES and VIBEDE. Lesion detectability was rated by both readers significantly better in VIBEDE with a median of 4 (0) compared with a median of 4 (1) for reader 1 and a median of 3 (1) for reader 2 (P = 0.001 for reader 1; P < 0.001 for reader 2). Consequently, diagnostic confidence was also significantly superior in VIBEDE versus VIBES with a median of 4 (0) for both (P = 0.001). Interreader agreement resulted in a Cohen κ of 0.76 for precontrast analysis as well as of 0.76 for postcontrast analysis.
CONCLUSIONS: Application of a novel iterative denoising and image enhancement technique in T1-weighted VIBE precontrast and postcontrast imaging of the abdomen is feasible, providing superior image quality, noise levels, and diagnostic confidence.
引用
- Gassenmaier S, Afat S, Nickel D, et al. Application of a Novel Iterative Denoising and Image Enhancement Technique in T1-Weighted Precontrast and Postcontrast Gradient Echo Imaging of the Abdomen: Improvement of Image Quality and Diagnostic Confidence. Invest Radiol. 2021. PMID: 33214390. doi:10.1097/RLI.0000000000000746
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。